Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between 40 and 65 years of age
- People who have been diagnosed with locally advanced breast cancer, confirmed through a tissue sample analysis
- People who are planned to receive chemotherapy before surgery (to shrink the tumour first)
- People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scale (confirm with trial site)
- People who are able to give their agreement to take part after being fully informed about the trial
- People who are willing to attend and take part in sessions focused on psychological support
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose psychological stress levels are measured as very high using a specific questionnaire called the Perceived Stress Scale (a score of 27 or above)
- People who currently have an active infection or an inflammatory condition
- People who have a known autoimmune disease (where the body's immune system attacks its own tissues)
- People who have a cognitive impairment or a mental health condition that would make it difficult to take part in the trial
- People who are already taking part in another clinical trial that involves an active treatment or intervention
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Asdi Wihandono, MD, Surgical Oncologist, Universitas Airlangga
Phone: +6281906000050
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Clinical response according to RECIST version 1.1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.